International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a key field of research in clinical epidemiology. However, the prognostic capacity of a marker is not systematically evaluated using the appropriate methodology. We proposed the use of simple equations to calculate time-dependent sensitivity and specificity based on published survival curves and other time-dependent indicators as pre-dictive values, likelihood ratios, and posttest probability ratios to reappraise prognostic marker accuracy.Study Design and Setting: The methodology is illustrated by back calculating time-dependent indicators from published articles presenting a marker as highly correlated with the time to event, concluding on t...
IMPORTANCE Prognostication is an important aspect of clinical decision-making, but it is often chall...
For many medical conditions there are several treatment options available to patients. We consider ...
Background: Poor reporting compromises the reliability and clinical value of prognostic tumour marke...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
The assessment of prognostic markers is key to the improvement of therapeutic strategies for cancer ...
International audienceMeta-analyses are popular tools to summarize the results of publications. Prog...
In a prospective cohort study, information on clinical parameters, tests and molecular markers is of...
Meta-analyses are popular tools to summarize the results of publications. Prognostic performances of...
Prognostic markers can help to identify patients at different degrees of risk for specific outcomes,...
Survival time prediction is important in many applications, particularly for patients diagnosed with...
Treatment selection markers, sometimes called predictive markers, are factors that help clinicians s...
Prognostic markers can help to identify patients at different degrees of risk for specific outcomes,...
Survival curves are a popular tool for representing the association between a binary marker and the ...
Measures of the impact of cancer on survival are often incomplete, and are subject to biases which c...
The question of how individual patient data from cohort studies or historical clinical trials can be...
IMPORTANCE Prognostication is an important aspect of clinical decision-making, but it is often chall...
For many medical conditions there are several treatment options available to patients. We consider ...
Background: Poor reporting compromises the reliability and clinical value of prognostic tumour marke...
International audienceObjectives: Predicting chronic disease evolution from a prognostic marker is a...
The assessment of prognostic markers is key to the improvement of therapeutic strategies for cancer ...
International audienceMeta-analyses are popular tools to summarize the results of publications. Prog...
In a prospective cohort study, information on clinical parameters, tests and molecular markers is of...
Meta-analyses are popular tools to summarize the results of publications. Prognostic performances of...
Prognostic markers can help to identify patients at different degrees of risk for specific outcomes,...
Survival time prediction is important in many applications, particularly for patients diagnosed with...
Treatment selection markers, sometimes called predictive markers, are factors that help clinicians s...
Prognostic markers can help to identify patients at different degrees of risk for specific outcomes,...
Survival curves are a popular tool for representing the association between a binary marker and the ...
Measures of the impact of cancer on survival are often incomplete, and are subject to biases which c...
The question of how individual patient data from cohort studies or historical clinical trials can be...
IMPORTANCE Prognostication is an important aspect of clinical decision-making, but it is often chall...
For many medical conditions there are several treatment options available to patients. We consider ...
Background: Poor reporting compromises the reliability and clinical value of prognostic tumour marke...